Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tingting Zhou, Xiaodong Huang, Xiaoqi Cai & Liangdi Xie. (2017) Combined treatment of irbesartan and diltiazem ameliorates endothelium dependent vasodilatation in hypertensives. Clinical and Experimental Hypertension 39:7, pages 612-618.
Read now
Read now
Norio Susa, Yayoi Nishida, Yoichi Yada, Tomohiro Nakayama, Satoshi Asai & Yasuo Takahashi. (2016) Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study. Clinical and Experimental Hypertension 38:2, pages 173-179.
Read now
Read now
Hee-Won Jung, Kwang-il Kim, Chang Gyu Park, Duk-Hyun Kang, Youngkeun Ahn, Jang Ho Bae & Cheol-Ho Kim. (2015) A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study). Clinical and Experimental Hypertension 37:6, pages 482-489.
Read now
Read now
Giuseppe Derosa, Arrigo F.G. Cicero, Anna Carbone, Fabrizio Querci, Elena Fogari, Angela D’Angelo & Pamela Maffioli. (2013) Olmesartan/Amlodipine Combination Versus Olmesartan or Amlodipine Monotherapies on Blood Pressure and Insulin Resistance in a Sample of Hypertensive Patients. Clinical and Experimental Hypertension 35:5, pages 301-307.
Read now
Read now
Articles from other publishers (19)
Michel Burnier, Josep Redon & Massimo Volpe. (2023) Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations. High Blood Pressure & Cardiovascular Prevention 30:2, pages 109-121.
Crossref
Crossref
Dnyaneshwar Purushottam Gholap, Ramdas Huse, Sudarshan Dipake & Machhindra K. Lande. (2023)
Silica supported lanthanum trifluoroacetate and trichloroacetate as an efficient and reusable water compatible Lewis acid catalyst for synthesis of 2,4,5-triarylimidazoles
via
a solvent-free green approach
. RSC Advances 13:3, pages 2090-2103.
Crossref
Crossref
R. González, G. Torrado, J.M. Arribas & M.A. Peña. (2022) Development of an analytical method for the determination and quantification of n-nitrosodimethylamine in olmesartan by HPLC-MS/MS. Microchemical Journal 179, pages 107402.
Crossref
Crossref
Riccardo Sarzani, Giorgia Laureti, Alessandro Gezzi, Francesco Spannella & Federico Giulietti. (2022) Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient. Therapeutic Advances in Chronic Disease 13, pages 204062232211027.
Crossref
Crossref
Mengjie Wang, Huanhuan Shi, Shuai Shao, Kun Lu, Hanyu Wang, Yun Yang, Zhimin Gong, Yuegang Zuo & Shixiang Gao. (2022) Montmorillonite promoted photodegradation of amlodipine in natural water via formation of surface complexes. Chemosphere 286, pages 131641.
Crossref
Crossref
Bjad K. Almutairy, Abdullah Alshetaili, Amer S. Alali, Mohammed Muqtader Ahmed, Md. Khalid Anwer & M. Ali Aboudzadeh. (2021) Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments. Polymers 13:14, pages 2272.
Crossref
Crossref
Chetan K. Jadhav, Amol S. Nipate, Asha V. Chate, Pratiksha M. Kamble, Ganesh A. Kadam, Vidya S. Dofe, Vijay M. Khedkar & Charansingh H. Gill. (2021) Room temperature ionic liquid promoted improved and rapid synthesis of highly functionalized imidazole and evaluation of their inhibitory activity against human cancer cells. Journal of the Chinese Chemical Society 68:6, pages 1067-1081.
Crossref
Crossref
Stefano Omboni, Kazuomi Kario, George Bakris & Gianfranco Parati. (2018) Effect of antihypertensive treatment on 24-h blood pressure variability. Journal of Hypertension 36:4, pages 720-733.
Crossref
Crossref
Xiaoshen Zhang, Han Zhang, Yuxia Ma, Wenliang Che & Michael R. Hamblin. (2017) Management of Hypertension Using Olmesartan Alone or in Combination. Cardiology and Therapy 6:1, pages 13-32.
Crossref
Crossref
G. Kourlaba, F. Gialama, K. Tsioufis & N. Maniadakis. (2016) A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients. International Journal of Cardiology 221, pages 60-74.
Crossref
Crossref
Miriam LeviAlessandro PasquaIacopo CricelliClaudio CricelliCarlo PiccinniDamiano ParrettiFrancesco Lapi. (2016) Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations. Journal of Managed Care & Specialty Pharmacy 22:3, pages 255-262.
Crossref
Crossref
Josep Redon & Gernot Pichler. (2016) Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes. Journal of Hypertension 34:2, pages 359-367.
Crossref
Crossref
Anna Jakimska, Magdalena Śliwka-Kaszyńska, Piotr Nagórski, Jacek Namieśnik & Agata Kot-Wasik. (2014) Phototransformation of Amlodipine: Degradation Kinetics and Identification of Its Photoproducts. PLoS ONE 9:10, pages e109206.
Crossref
Crossref
Joel M Neutel. (2013) Treatment algorithms for hypertension: a practical approach. Clinical Practice 10:3, pages 333-344.
Crossref
Crossref
Francesco Rozza, Valentina Trimarco, Raffaele Izzo, Mario Santoro, Maria Virginia Manzi, Marina Marino, Gianfranco Di Renzo & Bruno Trimarco. (2013) Antihypertensive Response to Combination of Olmesartan and Amlodipine Does Not Depend on Method and Time of Drug Administration. High Blood Pressure & Cardiovascular Prevention 20:1, pages 25-32.
Crossref
Crossref
Ravi Nistala & James R. Sowers. (2012) Synergy of antihypertensives in elderly patients with CKD. Nature Reviews Nephrology 9:1, pages 13-15.
Crossref
Crossref
Julián Segura. (2013) Olmesartán con diuréticos o con antagonistas del calcio: ¿a qué perfil de paciente hipertenso?. Hipertensión y Riesgo Vascular 30, pages 16-20.
Crossref
Crossref
Xia Chen, Pei Hu, Ji Jiang, Tao Liu, Wen Zhong, Hongzhong Liu & Qian Zhao. (2012) Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females. Clinical Drug Investigation 32:12, pages 783-790.
Crossref
Crossref
Arya M. Sharma, George Bakris, Joel M. Neutel, Thomas W. Littlejohn, Maureen Kobe, Naitee Ting & Ludwin Ley. (2012) Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial. Clinical Therapeutics 34:3, pages 537-551.
Crossref
Crossref